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Endobronchial metastasis is defined by bronchoscopically vis-
ible extrapulmonary tumors with lesions histologically identical 
to the primary tumors. Carcinomas of the breast, kidney, and 
colorectum are the most commonly encountered solid tumors 
causing endobronchial metastases,1 whereas such metastases 
arising from the tumors of uterine cervix are relatively rare. While 
there have been many case reports on endobronchial metastasis 
of uterine cervical squamous cell carcinoma, there is only one 
reported case of metastatic endobronchial adenocarcinoma from 
the uterine cervix2 and this report focused only on endoscopic 
treatment. Herein, we report a case of metastatic endobronchial 
adenocarcinoma from the uterine cervix with discuss on the dif-
ferential diagnosis.
CASE REPORT
A 59-year-old woman presented with cough, sputum, and 
dyspnea on exertion. Four years previously, she was diagnosed 
with uterine cervical cancer and had undergone radical hyster-
ectomy and bilateral salpingo-oophorectomy with adjuvant ra-
diotherapy in an overseas hospital. Chest computed tomogra-
phy revealed an endobronchial mass in the distal right main 
bronchus. Whole body positron emission tomography (PET) 
showed intense 18F-fluorodeoxyglucose uptake in the endo-
bronchial mass with no other abnormally hypermetabolic le-
sions. Bronchoscopic examination with biopsy was performed, 
and the pathologic finding was poorly differentiated carcinoma 
with necrosis and focal mucin formation (Fig. 1A). The tumor 
had been considered as poorly differentiated pulmonary adeno-
carcinoma, but it was negative for thyroid transcription factor-1 
(TTF-1) and napsin A immunostaining. The patient underwent 
right pneumonectomy with mediastinal lymph node dissection.
Macroscopically, a 6.5-cm-sized endobronchial mass was not-
ed originating from the right lower lobar bronchus. Microscop-
ically, the tumor showed large, confluent cribriform glands with 
focal papillary growth and intraluminal necrotic debris (Fig. 1B). 
The tumor cells were tall and columnar, showing elongated, ve-
sicular nuclei and amphophilic cytoplasm. Metastases to the 
peribronchial and subcarinal lymph nodes were observed. Since 
the microscopic findings were unusual for primary lung adeno-
carcinoma and the patient had a history of uterine cancer, ex-
tensive immunohistochemical staining was performed. The tu-
mor was positive for cytokeratin (CK) 7, carcinoembryonic an-
tigen, and p16, and negative for TTF-1, napsin A, estrogen re-
ceptor, progesterone receptor, vimentin, CK20, and caudal-re-
lated homeobox gene 2 (Fig. 1C, D). Human papillomavirus 
(HPV) genotyping (GeneFinder HPV Liquid Bead Microarray 
Kit, Infopia, Anyang, Korea) revealed the presence of HPV type 
18 genome in the tumor. The final pathological diagnosis was 
metastatic adenocarcinoma from the uterine endocervix.
DISCUSSION
Diffuse positive immunostaining for p16 is a good surrogate 
marker of high-risk HPV infection in uterine cervical and oro-
pharyngeal cancer.3 Primary lung cancers can also overexpress 
p16, but mainly in a focal distribution in approximately 32% 
of cases.4 However, high-risk HPV genomes are nearly nonexis-
Journal of Pathology and Translational Medicine  2015; 49: 174-176
http://dx.doi.org/10.4132/jptm.2015.02.10
▒ BRIEF CASE REPORT ▒
Corresponding Author
Heae Surng Park, M.D.
Department of Pathology, Gangnam Severance Hospital, Yonsei University College of 
Medicine, 211 Eonju-ro, Gangnam-gu, Seoul 135-720, Korea
Tel: +82-2-2019-3545, Fax: +82-2-3463-2103, E-mail: turtle98p@yuhs.ac
Received: January 23, 2015 Accepted: February 10, 2015
Metastatic Endobronchial Adenocarcinoma from the Uterine Cervix 
Verified by Human Papillomavirus Genotyping
Jisup Kim · Sungsoo Lee1 · Heae Surng Park
Departments of Pathology and 1Thoracic and Cardiovascular Surgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
http://jpatholtm.org/http://dx.doi.org/10.4132/jptm.2015.02.10
Metastatic Endocervical Cancer to Bronchus • 175
tent in lung cancer.4,5 Accordingly, confirmation of HPV infec-
tion is important to determine whether lung tumor has metas-
tasized from an HPV-associated primary cancer elsewhere in the 
body, such as the uterine cervix. In this case, HPV type 18 was 
detected in the tumor and a diagnosis of metastatic endocervi-
cal adenocarcinoma was made although the primary cancer tis-
sue was no longer available.
At the time of bronchoscopic biopsy, the patient’s history of 
uterine cancer was not known and whole body PET showed no 
other abnormal lesions except the endobronchial mass. Retro-
spective pathologic review of the biopsy showed no specific his-
tologic findings to suggest uterine endocervical adenocarcino-
ma. While positive immunostaining for both TTF-1 and nap-
sin A is highly specific and relatively sensitive for primary lung 
adenocarcinoma, negative immunostaining for both TTF-1 and 
napsin A has been reported in a small fraction of primary lung 
adenocarcinoma.6 Therefore, primary lung adenocarcinoma could 
not be excluded from the biopsy specimen alone. Since the tu-
mor was an endobronchial lesion, mucoepidermoid carcinoma 
was considered in the differential diagnosis. We retrospectively 
performed immunohistochemical staining for p16 as well as 
paired box 8 (PAX8), which is expressed in carcinomas arising 
in the endometrium, endocervix, ovary, thyroid, kidney, and 
urothelium. The tumor from the bronchoscopic biopsy showed 
positive immunoreactivity for p16, but negative immunoreac-
tivity for PAX8.
Diagnosis of an extrapulmonary malignancy in a small biop-
sy is challenging in the absence of information on the patient’s 
history of cancer. A combination of TTF-1 and napsin A im-
munostaining is useful to differentiate between pulmonary and 
extrapulmonary carcinoma in a proper clinical setting. When a 
non-squamous carcinoma from the bronchus is negative for both 
Fig. 1. (A) Histology of bronchoscopic biopsy shows poorly differentiated carcinoma with necrosis and focal mucin production (inset, muci-
carmine stain). (B) Histology of the pneumonectomy specimen shows confluent cribriform glands with focal papillary growth and intraluminal 
necrotic debris. Tall columnar tumor cells have elongated, vesicular nuclei and amphophilic cytoplasm (inset). (C) Immunohistochemical stain-
ing for p16 shows diffuse strong nuclear and cytoplasmic positivity in tumor cells. (D) Immunohistochemical staining for thyroid transcription 
factor-1 shows non-reactivity of tumor cells.
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TTF-1 and napsin A, the possibility of an extrapulmonary le-
sion may be considered and ancillary testing with clinical corre-
lation should be pursued.
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